• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉用药稀释液成分对重症监护病房患者电解质紊乱发生的影响:一项回顾性病历审查

Contribution of intravenous medication diluent fluid composition on the development of dyschloremia in intensive care unit patients: A retrospective chart review.

作者信息

Movahedan Mahsa, Brown Glen

机构信息

Intensive Care Unit, St. Paul's Hospital, Vancouver, BC, Canada.

出版信息

SAGE Open Med. 2025 Jul 17;13:20503121251356069. doi: 10.1177/20503121251356069. eCollection 2025.

DOI:10.1177/20503121251356069
PMID:40689261
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12276513/
Abstract

OBJECTIVE

Intravenous solutions such as dextrose 5% in water and 0.9% sodium chloride (normal saline) differ in electrolyte composition from human plasma and may contribute to serum chloride derangements (dyschloremia). This retrospective study aimed to explore the relationship between fluid composition, particularly medication diluents, and dyschloremia development in the intensive care unit.

METHODS

This was a retrospective chart review of adult intensive care unit patients with normal serum chloride on admission who developed dyschloremia after 48 h of intensive care unit admission. Data were collected on fluid types and volumes administered in the intensive care unit in the 7 days prior to dyschloremia onset. Descriptive statistics and chi-square tests were used to compare characteristics between patients who developed hyperchloremia and hypochloremia.

RESULTS

Of 884 screened patients, 85 developed dyschloremia after 48 h (41 hypochloremia, 44 hyperchloremia). There was no significant association between the proportion of normal saline or dextrose 5% in water-containing fluids and the type of dyschloremia. However, dexmedetomidine, typically diluted in normal saline, was associated with hyperchloremia.

CONCLUSION

While total fluid composition was not associated with dyschloremia type, high-volume use of specific diluent-medication combinations may contribute. Strategies to minimize diluent volume could help reduce dyschloremia risk.

摘要

目的

诸如5%葡萄糖水溶液和0.9%氯化钠(生理盐水)等静脉输液的电解质组成与人体血浆不同,可能导致血清氯紊乱(氯代谢异常)。这项回顾性研究旨在探讨液体组成,尤其是药物稀释剂,与重症监护病房中氯代谢异常发生之间的关系。

方法

这是一项对成年重症监护病房患者的回顾性病历审查,这些患者入院时血清氯正常,在重症监护病房入院48小时后发生氯代谢异常。收集在氯代谢异常发作前7天内在重症监护病房给予的液体类型和体积的数据。使用描述性统计和卡方检验来比较发生高氯血症和低氯血症患者之间的特征。

结果

在884名筛查患者中,85名在48小时后发生氯代谢异常(41名低氯血症,44名高氯血症)。生理盐水或含5%葡萄糖水溶液的液体比例与氯代谢异常类型之间没有显著关联。然而,通常用生理盐水稀释的右美托咪定与高氯血症有关。

结论

虽然总液体组成与氯代谢异常类型无关,但特定稀释剂 - 药物组合的大量使用可能有影响。尽量减少稀释剂体积的策略可能有助于降低氯代谢异常风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b92/12276513/0762c2500309/10.1177_20503121251356069-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b92/12276513/31e77344bb18/10.1177_20503121251356069-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b92/12276513/045ea69cbf44/10.1177_20503121251356069-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b92/12276513/061b49c73ea0/10.1177_20503121251356069-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b92/12276513/0762c2500309/10.1177_20503121251356069-fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b92/12276513/31e77344bb18/10.1177_20503121251356069-fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b92/12276513/045ea69cbf44/10.1177_20503121251356069-fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b92/12276513/061b49c73ea0/10.1177_20503121251356069-fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4b92/12276513/0762c2500309/10.1177_20503121251356069-fig4.jpg

相似文献

1
Contribution of intravenous medication diluent fluid composition on the development of dyschloremia in intensive care unit patients: A retrospective chart review.静脉用药稀释液成分对重症监护病房患者电解质紊乱发生的影响:一项回顾性病历审查
SAGE Open Med. 2025 Jul 17;13:20503121251356069. doi: 10.1177/20503121251356069. eCollection 2025.
2
Intravenous fluids for reducing the duration of labour in low risk nulliparous women.用于缩短低风险初产妇产程的静脉输液。
Cochrane Database Syst Rev. 2013 Jun 18;2013(6):CD007715. doi: 10.1002/14651858.CD007715.pub2.
3
Perioperative buffered versus non-buffered fluid administration for surgery in adults.成人手术围手术期使用缓冲液与非缓冲液进行液体输注的比较。
Cochrane Database Syst Rev. 2012 Dec 12;12:CD004089. doi: 10.1002/14651858.CD004089.pub2.
4
Perioperative administration of buffered versus non-buffered crystalloid intravenous fluid to improve outcomes following adult surgical procedures.围手术期给予缓冲与非缓冲晶体静脉输液以改善成人外科手术后的结局。
Cochrane Database Syst Rev. 2017 Sep 21;9(9):CD004089. doi: 10.1002/14651858.CD004089.pub3.
5
[Volume and health outcomes: evidence from systematic reviews and from evaluation of Italian hospital data].[容量与健康结果:来自系统评价和意大利医院数据评估的证据]
Epidemiol Prev. 2013 Mar-Jun;37(2-3 Suppl 2):1-100.
6
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
7
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
8
Ear drops for the removal of ear wax.用于清除耳垢的滴耳剂。
Cochrane Database Syst Rev. 2018 Jul 25;7(7):CD012171. doi: 10.1002/14651858.CD012171.pub2.
9
Use of biochemical tests of placental function for improving pregnancy outcome.利用胎盘功能生化检测改善妊娠结局。
Cochrane Database Syst Rev. 2015 Nov 25;2015(11):CD011202. doi: 10.1002/14651858.CD011202.pub2.
10
Comparison of routes for achieving parenteral access with a focus on the management of patients with Ebola virus disease.实现肠外通路的途径比较,重点关注埃博拉病毒病患者的管理。
Cochrane Database Syst Rev. 2015 Feb 26;2015(2):CD011386. doi: 10.1002/14651858.CD011386.pub2.

本文引用的文献

1
Fluid accumulation syndrome in sepsis and septic shock: pathophysiology, relevance and treatment-a comprehensive review.脓毒症和脓毒性休克中的液体蓄积综合征:病理生理学、相关性及治疗——一项全面综述
Ann Intensive Care. 2024 Jul 20;14(1):115. doi: 10.1186/s13613-024-01336-9.
2
Iatrogenic hyperchloremia: An overview in hospitalized patients for pharmacists.医源性高氯血症:住院患者的概述(面向药师)。
Am J Health Syst Pharm. 2024 Aug 19;81(17):e462-e470. doi: 10.1093/ajhp/zxae086.
3
Physical and Chemical Compatibility of Medications Commonly Used in Critically Ill Patients With Balanced Crystalloids: A Systematic Review.
危重症患者常用晶体液与药物的物理化学相容性:系统评价。
Ann Pharmacother. 2024 Mar;58(3):322-332. doi: 10.1177/10600280231179999. Epub 2023 Jun 21.
4
Association between serum chloride levels with mortality in critically ill patients with acute kidney injury: An observational multicenter study employing the eICU database.血清氯水平与急性肾损伤危重症患者死亡率的关系:一项采用 eICU 数据库的观察性多中心研究。
PLoS One. 2022 Aug 23;17(8):e0273283. doi: 10.1371/journal.pone.0273283. eCollection 2022.
5
Hidden Fluids in Plain Sight: Identifying Intravenous Medication Classes as Contributors to Intensive Care Unit Fluid Intake.一目了然的隐匿液体:确定静脉用药类别是重症监护病房液体摄入的因素
Hosp Pharm. 2022 Apr;57(2):230-236. doi: 10.1177/00185787211016339. Epub 2021 May 19.
6
Association of hyperchloremia with all-cause mortality in patients admitted to the surgical intensive care unit: a retrospective cohort study.高氯血症与外科重症监护病房患者全因死亡率的相关性:一项回顾性队列研究。
BMC Anesthesiol. 2022 Jan 7;22(1):14. doi: 10.1186/s12871-021-01558-5.
7
Association between the use of balanced fluids and outcomes in critically ill children: a before and after study.平衡液使用与危重症患儿结局的关联:一项前后对照研究。
Crit Care. 2021 Jul 29;25(1):266. doi: 10.1186/s13054-021-03705-3.
8
Comparison of Balanced Crystalloid Solutions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.平衡晶体溶液的比较:随机对照试验的系统评价和荟萃分析
Crit Care Explor. 2021 May 14;3(5):e0398. doi: 10.1097/CCE.0000000000000398. eCollection 2021 May.
9
Assessment and Impact of Intravenous Medication Fluid Administration in Critically Ill Patients With Acute Respiratory Failure.急性呼吸衰竭危重症患者静脉输液管理的评估与影响。
Ann Pharmacother. 2022 Jan;56(1):35-43. doi: 10.1177/10600280211013581. Epub 2021 May 5.
10
Association of hidden fluid administration with development of fluid overload reveals opportunities for targeted fluid minimization.隐匿性液体输注与液体超负荷发展之间的关联揭示了有针对性地减少液体量的机会。
SAGE Open Med. 2020 Dec 9;8:2050312120979464. doi: 10.1177/2050312120979464. eCollection 2020.